Leukemia & Lymphoma, Volume 49, Issue 4 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 49, Issue 4 (2008)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Volume 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Preface

Article
Targets and targeted drugs in chronic myeloid leukemia
Peter Valent
Page: 599
Published online: 01 Jul 2009
CitationforTargets and targeted drugs in chronic myeloid leukemia | Full Text | PDF (41.9 KB)
  • 19 Views
  • 0 CrossRef citations
  • 0Altmetric

Focused Reviews in CML

Article
Requirement of lipocalin 2 for chronic myeloid leukemia
Ralph Arlinghaus PhD & Xiaohong Leng
Pages: 600-603
Published online: 01 Jul 2009
AbstractforRequirement of lipocalin 2 for chronic myeloid leukemia | Full Text | References | PDF (893.1 KB)
  • 114 Views
  • 16 CrossRef citations
  • 0Altmetric
Review Article
Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia
Peter Valent & Michael Deininger
Pages: 604-609
Published online: 01 Jul 2009
AbstractforClinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia | Full Text | References | PDF (83.6 KB)
  • 105 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
BCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts
Tomasz Skorski
Pages: 610-614
Published online: 01 Jul 2009
AbstractforBCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts | Full Text | References | PDF (761.1 KB)
  • 468 Views
  • 51 CrossRef citations
  • 0Altmetric
Review Article
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib
Oliver Hantschel, Uwe Rix & Giulio Superti-Furga
Pages: 615-619
Published online: 01 Jul 2009
AbstractforTarget spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib | Full Text | References | PDF (423.1 KB)
  • 2676 Views
  • 195 CrossRef citations
  • 0Altmetric
Article
Signal interception-based therapies – A double-edged sword in Bcr/abl-induced malignancies?
Eva Zebedin, Michael Freissmuth & Veronika Sexl
Pages: 620-624
Published online: 01 Jul 2009
AbstractforSignal interception-based therapies – A double-edged sword in Bcr/abl-induced malignancies? | Full Text | References | PDF (212.2 KB)
  • 84 Views
  • 4 CrossRef citations
  • 0Altmetric
Review Article
New therapeutic approaches and prognostic factors in chronic myeloid leukemia
Giuseppe Saglio, Stefano Ulisciani, Marco Bosa, Daniela Cilloni & Giovanna Rege-Cambrin
Pages: 625-628
Published online: 01 Jul 2009
AbstractforNew therapeutic approaches and prognostic factors in chronic myeloid leukemia | Full Text | References | PDF (68.7 KB)
  • 75 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Immunotherapeutic approaches in chronic myelogenous leukemia
François Guilhot, Lydia Roy, Pierre-Jean Saulnier, Joëlle Guilhot, Anne Barra, Jean-Marc Gombert & Ali Turhan
Pages: 629-634
Published online: 01 Jul 2009
AbstractforImmunotherapeutic approaches in chronic myelogenous leukemia | Full Text | References | PDF (87.1 KB)
  • 87 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia
Peter Valent MD, Hermine Agis, Wolfgang Sperr, Christian Sillaber & Hans-Peter Horny
Pages: 635-638
Published online: 01 Jul 2009
AbstractforDiagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia | Full Text | References | PDF (119.5 KB)
  • 153 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia
Richard E. Clark, Andrea Davies, Munir Pirmohamed & Athina Giannoudis
Pages: 639-642
Published online: 01 Jul 2009
AbstractforPharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia | Full Text | References | PDF (124.5 KB)
  • 219 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia
Stefan Schmidt, Guenther Gastl & Dominik Wolf
Pages: 643-647
Published online: 01 Jul 2009
AbstractforPossible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia | Full Text | References | PDF (80 KB)
  • 55 Views
  • 6 CrossRef citations
  • 0Altmetric

Commentary

Article
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior?
Elena M. Hartmann & Andreas Rosenwald
Pages: 648-649
Published online: 01 Jul 2009
CitationforChronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior? | Full Text | References | PDF (54.8 KB)
  • 62 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
DNA methyltransferase inhibitors: Class effect or unique agents?
Elizabeth A. Griffiths & Steven D. Gore
Pages: 650-651
Published online: 01 Jul 2009
CitationforDNA methyltransferase inhibitors: Class effect or unique agents? | Full Text | References | PDF (54.4 KB)
  • 68 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
The development of novel immunotherapeutic approaches in multiple myeloma
Stefan Peinert, H. Miles Prince & Simon Harrison
Pages: 652-654
Published online: 01 Jul 2009
First Page PreviewforThe development of novel immunotherapeutic approaches in multiple myeloma | Full Text | References | PDF (61.2 KB)
  • 29 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Mantle, blastic, Burkitt
John Anastasi
Pages: 655-656
Published online: 01 Jul 2009
CitationforMantle, blastic, Burkitt | Full Text | References | PDF (50.8 KB)
  • 51 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Bortezomib: Putting mantle cell lymphoma on death row
Andrew H. Wei & Andrew W. Roberts
Pages: 657-658
Published online: 01 Jul 2009
CitationforBortezomib: Putting mantle cell lymphoma on death row | Full Text | References | PDF (57.5 KB)
  • 50 Views
  • 4 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Early interim PET scan in Hodgkin lymphoma: Where do we stand?
Andrea Gallamini, Martin Hutchings, Abraham Avigdor & Aaron Polliack
Pages: 659-662
Published online: 01 Jul 2009
AbstractforEarly interim PET scan in Hodgkin lymphoma: Where do we stand? | Full Text | References | PDF (217.9 KB)
  • 181 Views
  • 28 CrossRef citations
  • 0Altmetric
Review Article
Current treatment approaches for diffuse large B-cell lymphoma
Tim Illidge & Shaun Tolan
Pages: 663-676
Published online: 01 Jul 2009
AbstractforCurrent treatment approaches for diffuse large B-cell lymphoma | Full Text | References | PDF (575.6 KB)
  • 142 Views
  • 18 CrossRef citations
  • 0Altmetric
Review Article
Novel anti-myeloma agents and angiogenesis
Konstantinos Anargyrou, Meletios-Athanassios Dimopoulos, Orhan Sezer & Evangelos Terpos
Pages: 677-689
Published online: 01 Jul 2009
AbstractforNovel anti-myeloma agents and angiogenesis | Full Text | References | PDF (1.2 MB)
  • 238 Views
  • 35 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine
Gautam Borthakur M.D., Samih El Ahdab, Farhad Ravandi, Stefan Faderl, Alessandra Ferrajoli, Beth Newman, Jean-Pierre Issa & Hagop Kantarjian
Pages: 690-695
Published online: 01 Jul 2009
AbstractforActivity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine | Full Text | References | PDF (157.4 KB)
  • 556 Views
  • 89 CrossRef citations
  • 0Altmetric
Article
JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera
Sujiang Zhang, Hongxia Qiu, Bruce S. Fischer, Weida Li, Limin Duan, Xuemei Sun, Wei Xu & Jianyong Li
Pages: 696-699
Published online: 01 Jul 2009
AbstractforJAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera | Full Text | References | PDF (205.1 KB)
  • 114 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Prognostic implications of the immunophenotype in biphenotypic acute leukemia
Je-Hwan Lee, Yoo Hong Min M.D., Chul Won Chung, Byoung Kook Kim, Hwi-Joong Yoon, Deog-Yeon Jo, Ho-Jin Shin, Soo-Mee Bang, Jong-Ho Won, Dae Young Zang, Hyeoung Joon Kim, Hyun-Sook Chi, Kyoo-Hyung Lee, June-Won Cheong, Jin Seok Kim, Sun Hee Kim, Seonyang Park, Su Yon Park, Joo Seop Chung, Jae Hoon Lee, Chan-Jeoung Park M.D. & The Korean Society Of Hematology AML/MDS Working Party
Pages: 700-709
Published online: 01 Jul 2009
AbstractforPrognostic implications of the immunophenotype in biphenotypic acute leukemia | Full Text | References | PDF (260.9 KB)
  • 325 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics
Naveed I. Khan, Adam Cisterne, Meenakshi Devidas, Jonathan Shuster, Stephen P. Hunger, Peter J. Shaw, Kenneth F. Bradstock & Linda J. Bendall
Pages: 710-718
Published online: 01 Jul 2009
AbstractforExpression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics | Full Text | References | PDF (480.7 KB)
  • 109 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma
Sarah C. Rutherford, Biree Andemariam, Shibu M. Philips, Rebecca L. Elstrom, Amy Chadburn, Richard R. Furman, Ruben Niesvizky, Peter Martin, Thomas J. Fahey, Morton Coleman, Stanley J. Goldsmith & John P. Leonard
Pages: 719-726
Published online: 01 Jul 2009
AbstractforFDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma | Full Text | References | PDF (1.7 MB)
  • 183 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation
Roberto Crocchiolo MD, Carla Canevari, Andrea Assanelli, Francesca Lunghi, Michela Tassara, Maria Lupo Stanghellini, Daniela Clerici, Claudio Landoni, Paolo Servida, Massimo Bernardi, Jacopo Peccatori, Andres Ferreri, Luigi Gianolli, Claudio Bordignon, Federico Caligaris-Cappio, Fabio Ciceri & Ferruccio Fazio
Pages: 727-733
Published online: 01 Jul 2009
AbstractforPre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation | Full Text | References | PDF (239.1 KB)
  • 121 Views
  • 26 CrossRef citations
  • 0Altmetric
Article
Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: A report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group
Masahito Tsurusawa, Takashi Taga, Yasuo Horikoshi, Atsushi Ogawa, Atsushi Kikuta, Hirokazu Kanegane, Takeji Matsushita, Nobuyuki Hyakuna, Yasuto Shimomura, Koichi Ohshima & of the lymphoma committee of the Japanese Childhood Cancer and Leukemia Study Group
Pages: 734-739
Published online: 01 Jul 2009
AbstractforFavourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: A report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group | Full Text | References | PDF (220.7 KB)
  • 96 Views
  • 5 CrossRef citations
  • 0Altmetric
Review Article
Blastic mantle cell lymphoma with a Burkitt translocation
Kavita Reddy, Mohammad Ansari-Lari & Bruno Dipasquale
Pages: 740-750
Published online: 01 Jul 2009
AbstractforBlastic mantle cell lymphoma with a Burkitt translocation | Full Text | References | PDF (911.2 KB)
  • 216 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators
Zhifeng Yu, Baohua Sun, Hagop M. Kantarjian, Michael J. Keating, Hesham M. Amin & Xiaoping Sun MD, PhD
Pages: 751-756
Published online: 01 Jul 2009
AbstractforProtein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators | Full Text | References | PDF (287.8 KB)
  • 159 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol
Akira Kikuchi MD, Tetsuya Mori, Jun-Ichiro Fujimoto, Masaaki Kumagai, Shosuke Sunami, Yuri Okimoto & Masahiro Tsuchida
Pages: 757-762
Published online: 01 Jul 2009
AbstractforOutcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol | Full Text | References | PDF (188.3 KB)
  • 105 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia
Leeona Galligan, Mark A. Catherwood, Christine Matthews, T. C. M ‘Curly' Morris & H Dennis Alexander
Pages: 763-768
Published online: 01 Jul 2009
AbstractforMutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia | Full Text | References | PDF (80.8 KB)
  • 133 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients
Saad Akhtar, Amr El Weshi, Mohemmed Rahal, Yasser Khafaga, Abdelghani Tbakhi, Hind Humaidan & Irfan Maghfoor
Pages: 769-778
Published online: 01 Jul 2009
AbstractforFactors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients | Full Text | References | PDF (108.3 KB)
  • 194 Views
  • 52 CrossRef citations
  • 0Altmetric
Article
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma
Christian Frank, Michael Hundemer, Anthony D. Ho, Hartmut Goldschmidt & Mathias Witzens-Harig
Pages: 779-785
Published online: 01 Jul 2009
AbstractforCellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma | Full Text | References | PDF (660.9 KB)
  • 81 Views
  • 18 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
David J. Adams, Marit L. Sandvold, Finn Myhren, Tove F. Jacobsen, Frank Giles & David A. Rizzieri
Pages: 786-797
Published online: 01 Jul 2009
AbstractforAnti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells | Full Text | References | PDF (1.9 MB)
  • 810 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access

Original Articles: Research

Article
Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways
Edgar Gil Rizzatti, Helena Mora-Jensen, Marc Andrée Weniger, Federica Gibellini, Elinor Lee, Masanori Daibata, Raymond Lai & Adrian Wiestner MD, PhD
Pages: 798-808
Published online: 01 Jul 2009
AbstractforNoxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways | Full Text | References | PDF (1.3 MB)
  • 451 Views
  • 48 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Pharmacokinetic self-potentiation of idarubicin by induction of anthracycline carbonyl reducing enzymes
Taro Yamashita, Toshihiro Fukushima & Takanori Ueda
Pages: 809-814
Published online: 01 Jul 2009
AbstractforPharmacokinetic self-potentiation of idarubicin by induction of anthracycline carbonyl reducing enzymes | Full Text | References | PDF (266.1 KB)
  • 61 Views
  • 2 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy
Pierre-Jean Saulnier, Florence Dalbiès, Christian Berthou, François Guilhot, Nicolas Bourmeyster, Jean-claude Chomel & Ali Thuran
Pages: 815-816
Published online: 01 Jul 2009
CitationforProlonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy | Full Text | References | PDF (56.7 KB)
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Acute myeloid leukemia in Jehovah Witnesses
Nicole M. Brown, Gina Keck & Patricia A. Ford
Pages: 817-820
Published online: 01 Jul 2009
First Page PreviewforAcute myeloid leukemia in Jehovah Witnesses | Full Text | References | PDF (168.5 KB)
  • 471 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Simultaneous double mismatched cord blood transplantation in a young patient with secondary myelodysplastic syndrome: Feasibility and complications
Michela Tarnani, Luca Laurenti MD, Patrizia Chiusolo, Federica Sorà, Idanna Innocenti, Giuseppe Leone & Simona Sica
Pages: 821-823
Published online: 01 Jul 2009
First Page PreviewforSimultaneous double mismatched cord blood transplantation in a young patient with secondary myelodysplastic syndrome: Feasibility and complications | Full Text | References | PDF (58.7 KB)
  • 10 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians
Tham Chee Kian, Tao Miriam, Quek Richard, Yap Swee Peng, Loong Er Li, Sng Ivy, Tan Leonard Hwan-Cheong, Li Hui Hua & Lim Soon Thye
Pages: 824-827
Published online: 01 Jul 2009
First Page PreviewforClinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians | Full Text | References | PDF (103.4 KB)
  • 59 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Biclonal T-cell receptor gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthritis
Monika Prochorec-Sobieszek, Monika Chełstowska, Grzegorz Rymkiewicz, Mirosław Majewski, Krzysztof Warzocha & Renata Maryniak
Pages: 828-831
Published online: 01 Jul 2009
First Page PreviewforBiclonal T-cell receptor gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthritis | Full Text | References | PDF (641.6 KB)
  • 74 Views
  • 3 CrossRef citations
  • 0Altmetric

Erratum

Correction
Erratum
Page: 832
Published online: 01 Jul 2009
CitationforErratum | Full Text | PDF (35.5 KB)
  • 432 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles